دورية أكاديمية
The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease
العنوان: | The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease |
---|---|
المؤلفون: | Fu, Guangzhen, Hu, Mei, Chu, Lina, Zhang, Man |
المساهمون: | Zhang, M (reprint author), Peking Univ Ninth Sch Clin Med, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China., Peking Univ Ninth Sch Clin Med, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China., Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China. |
المصدر: | SCI ; PubMed |
بيانات النشر: | INTERNATIONAL JOURNAL OF ENDOCRINOLOGY |
سنة النشر: | 2015 |
المجموعة: | Peking University Institutional Repository (PKU IR) / 北京大学机构知识库 |
مصطلحات موضوعية: | CARDIOVASCULAR-DISEASE, FIBRINOPEPTIDE-A, RISK-FACTORS, BIOMARKERS, DISCOVERY, FIBRINOGEN, PROTEOMICS, MELLITUS, CANCER, HEART |
الوصف: | Objectives. We aim to explore urinary biomarkers that could monitor CAD in type 2 diabetic patients. Materials and Methods. Urine samples from two groups, twenty-eight type 2 diabetic patients with coexisting CAD and thirty type 2 diabetic patients without CAD, were purified by MB-WCX and then analyzed by MALDI-TOF-MS. Subsequently, we compared the urinary peptide signatures of the two groups by use of ClinProTools2.1 and evaluated the potential ability of the differently expressed peptides to distinguish type 2 diabetic patients with coexisting CAD from type 2 diabetic patients without CAD by ROC analysis. Finally, the differently expressed peptides were identified by nanoliquid chromatography-tandem mass spectrometry. Results. There were six differently expressed peptides (m/z 1305.2, 1743.9, 2184.9, 2756.1, 3223.2, and 6196.1) between the two groups of subjects, and they were identified as fragments of isoform 1 of fibrinogen alpha chain precursor, prothrombin precursor, and interalpha-trypsin inhibitor heavy chain H4. The diagnostic efficacy of m/z 2756.1 and m/z 3223.2 was better than the other peptides. Area under ROC of the m/z 2756.1, and m/z 3223.2 was 0.98 and 0.93, respectively. Conclusions. These urinary peptides are potential urinary biomarkers for monitoring of type 2 diabetic patients with CAD. ; Capital Health Research and Development of Special [2011-2008-02]; National Key Technology R&D Program: Key technology and application research of pre-pregnacy eugenics [2013BAI12B01-4] ; SCI(E) ; PubMed ; ARTICLE ; mzhang99@aliyun.com ; 758402 ; 2015 |
نوع الوثيقة: | journal/newspaper |
اللغة: | English |
تدمد: | 1687-8337 1687-8345 |
العلاقة: | INTERNATIONAL JOURNAL OF ENDOCRINOLOGY.2015.; 1302773; http://hdl.handle.net/20.500.11897/419235Test; WOS:000355463600001 |
DOI: | 10.1155/2015/758402 |
الإتاحة: | https://doi.org/20.500.11897/419235Test https://doi.org/10.1155/2015/758402Test https://hdl.handle.net/20.500.11897/419235Test |
رقم الانضمام: | edsbas.F4DA55F3 |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.F4DA55F3 792 3 Academic Journal academicJournal 792.1474609375 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.F4DA55F3&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/20.500.11897/419235# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsbas&genre=article&issn=16878337&ISBN=&volume=&issue=&date=20150101&spage=&pages=&title=SCI ; PubMed&atitle=The%20Difference%20Quantity%20of%20Urinary%20Peptides%20between%20Two%20Groups%20of%20Type%202%20Diabetic%20Patients%20with%20or%20without%20Coronary%20Artery%20Disease&id=DOI:10.1155/2015/758402 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Fu%2C+Guangzhen%22">Fu, Guangzhen</searchLink><br /><searchLink fieldCode="AR" term="%22Hu%2C+Mei%22">Hu, Mei</searchLink><br /><searchLink fieldCode="AR" term="%22Chu%2C+Lina%22">Chu, Lina</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Man%22">Zhang, Man</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Zhang, M (reprint author), Peking Univ Ninth Sch Clin Med, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China.<br />Peking Univ Ninth Sch Clin Med, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China.<br />Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China. ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => SCI ; PubMed ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => INTERNATIONAL JOURNAL OF ENDOCRINOLOGY ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2015 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Peking University Institutional Repository (PKU IR) / 北京大学机构知识库 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22CARDIOVASCULAR-DISEASE%22">CARDIOVASCULAR-DISEASE</searchLink><br /><searchLink fieldCode="DE" term="%22FIBRINOPEPTIDE-A%22">FIBRINOPEPTIDE-A</searchLink><br /><searchLink fieldCode="DE" term="%22RISK-FACTORS%22">RISK-FACTORS</searchLink><br /><searchLink fieldCode="DE" term="%22BIOMARKERS%22">BIOMARKERS</searchLink><br /><searchLink fieldCode="DE" term="%22DISCOVERY%22">DISCOVERY</searchLink><br /><searchLink fieldCode="DE" term="%22FIBRINOGEN%22">FIBRINOGEN</searchLink><br /><searchLink fieldCode="DE" term="%22PROTEOMICS%22">PROTEOMICS</searchLink><br /><searchLink fieldCode="DE" term="%22MELLITUS%22">MELLITUS</searchLink><br /><searchLink fieldCode="DE" term="%22CANCER%22">CANCER</searchLink><br /><searchLink fieldCode="DE" term="%22HEART%22">HEART</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Objectives. We aim to explore urinary biomarkers that could monitor CAD in type 2 diabetic patients. Materials and Methods. Urine samples from two groups, twenty-eight type 2 diabetic patients with coexisting CAD and thirty type 2 diabetic patients without CAD, were purified by MB-WCX and then analyzed by MALDI-TOF-MS. Subsequently, we compared the urinary peptide signatures of the two groups by use of ClinProTools2.1 and evaluated the potential ability of the differently expressed peptides to distinguish type 2 diabetic patients with coexisting CAD from type 2 diabetic patients without CAD by ROC analysis. Finally, the differently expressed peptides were identified by nanoliquid chromatography-tandem mass spectrometry. Results. There were six differently expressed peptides (m/z 1305.2, 1743.9, 2184.9, 2756.1, 3223.2, and 6196.1) between the two groups of subjects, and they were identified as fragments of isoform 1 of fibrinogen alpha chain precursor, prothrombin precursor, and interalpha-trypsin inhibitor heavy chain H4. The diagnostic efficacy of m/z 2756.1 and m/z 3223.2 was better than the other peptides. Area under ROC of the m/z 2756.1, and m/z 3223.2 was 0.98 and 0.93, respectively. Conclusions. These urinary peptides are potential urinary biomarkers for monitoring of type 2 diabetic patients with CAD. ; Capital Health Research and Development of Special [2011-2008-02]; National Key Technology R&D Program: Key technology and application research of pre-pregnacy eugenics [2013BAI12B01-4] ; SCI(E) ; PubMed ; ARTICLE ; mzhang99@aliyun.com ; 758402 ; 2015 ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1687-8337<br />1687-8345 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => INTERNATIONAL JOURNAL OF ENDOCRINOLOGY.2015.; 1302773; http://hdl.handle.net/20.500.11897/419235; WOS:000355463600001 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1155/2015/758402 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/20.500.11897/419235<br />https://doi.org/10.1155/2015/758402<br />https://hdl.handle.net/20.500.11897/419235 ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.F4DA55F3 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1155/2015/758402
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => CARDIOVASCULAR-DISEASE
[Type] => general
)
[1] => Array
(
[SubjectFull] => FIBRINOPEPTIDE-A
[Type] => general
)
[2] => Array
(
[SubjectFull] => RISK-FACTORS
[Type] => general
)
[3] => Array
(
[SubjectFull] => BIOMARKERS
[Type] => general
)
[4] => Array
(
[SubjectFull] => DISCOVERY
[Type] => general
)
[5] => Array
(
[SubjectFull] => FIBRINOGEN
[Type] => general
)
[6] => Array
(
[SubjectFull] => PROTEOMICS
[Type] => general
)
[7] => Array
(
[SubjectFull] => MELLITUS
[Type] => general
)
[8] => Array
(
[SubjectFull] => CANCER
[Type] => general
)
[9] => Array
(
[SubjectFull] => HEART
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Fu, Guangzhen
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hu, Mei
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Chu, Lina
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Zhang, Man
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Zhang, M (reprint author), Peking Univ Ninth Sch Clin Med, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China.
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Peking Univ Ninth Sch Clin Med, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China.
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2015
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 16878337
)
[1] => Array
(
[Type] => issn-print
[Value] => 16878345
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => SCI ; PubMed
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |